Katsuhisa Kawanami

Dr. Katsuhisa Kawanami

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2016 in Journal of Orthopaedics
Verified
Journal Article
Closed access
KKKatsuhisa Kawanami
Katsuhisa Kawanami
TMToshihiro Matsuo
Toshihiro Matsuo
MDMasataka Deie
Masataka Deie
YIYasunori Izuta
Yasunori Izuta
NWNorimitsu Wakao
Norimitsu Wakao
AHAtsuhiko Hirasawa
Atsuhiko Hirasawa

7 May 2018 in Journal of Orthopaedics
Verified
Journal Article
Closed access
RTRyosuke Takahashi
Ryosuke Takahashi
TMToshihiro Matsuo
Toshihiro Matsuo
KKKatsuhisa Kawanami
Katsuhisa Kawanami
TTTakuya Takata
Takuya Takata
ETEmiko Takahashi
Emiko Takahashi
MDMasataka DEIE
Masataka DEIE

6 July 2021 in Preprints.org
Verified
Preprint
Open access
PDF file
HAHisaki Aiba
Hisaki Aiba
KIKunihiro Ikuta
Kunihiro Ikuta
KAKunihiro Asanuma
Kunihiro Asanuma
KKKatsuhisa Kawanami
Katsuhisa Kawanami
STSatoshi Tsukushi
Satoshi Tsukushi
YNYoshihiro Nishida
Yoshihiro Nishida
Several types of soft tissue sarcomas have peripheral infiltrative growth characteristics called tail-like lesions. The efficacy of neoadjuvant therapy for tumors with tail-like lesions has not been elucidated. From 2012 to 2019, we analyzed 36 patients with soft tissue sarcoma with tail-like lesions treated with neoadjuvant therapy, including chemotherapy, radiotherapy, or both. The ef-fect of neoadjuvant therapy on the tail sign was investigated by analyzing the change in tail-like lesions during neoadjuvant therapy and histological responses. The median length of the tail-like lesion reduced from 29.5 mm at initiation to 19.5 mm after neoadjuvant therapy. The extent of shrinkage in tail-like lesion was related to the histopathological responses in the main part. Com-plete disappearance of the tail-like lesion was observed in 12 patients; however, it was not related to achieving a microscopically negative margin. The oncologic outcomes did not significantly differ between cases with complete disappearance of tail-like lesions or not. This study indicated the shrinkage of tail-like lesions did not have significant effect on complete resection or improve-ment of clinical outcomes. A more comprehensive evaluation is needed to elaborate on the surgi-cal strategy.

1 January 2021 in Journal of Orthopaedics
Verified
Journal Article
Closed access
KKKatsuhisa Kawanami
Katsuhisa Kawanami
AHAtsuhiko Hirasawa
Atsuhiko Hirasawa
MDMasataka Deie
Masataka Deie

4 June 2026 in Cancers
Verified
Journal Article
Open access
PDF file
TNTomoki Nakamura
Tomoki Nakamura
STSatoshi Tsukushi
Satoshi Tsukushi
ANAkihito Nagano
Akihito Nagano
TSTomohisa Sakai
Tomohisa Sakai
HAHisaki Aiba
Hisaki Aiba
YNYoshihiro Nishida
Yoshihiro Nishida
Background/Objectives: Chemotherapy is recommended for patients with advanced soft tissue sarcoma (STS). However, chemotherapy is less aggressive in elderly patients than in younger patients owing to comorbidities and other health problems. This multicenter study aimed to examine the outcomes of elderly patients treated with chemotherapy for advanced STS. Methods: The study cohort included 60 men and 71 women with a mean age of 73 years. The mean follow-up duration was 22.9 months. Results: As first-line treatment, the doxorubicin-containing regimen was the most frequently used. Dose reduction was more frequent in patients aged ≥ 75 years than in those aged ≤ 74 years. Complete response occurred in two patients and partial response in eight patients. The objective response rate was 8.2%. The 1- and 2-year survival rates after first-line chemotherapy were 61.8% and 40.2%, respectively. The median survival time was 19 months. In multivariate analysis, patients with performance status (PS) 2 or 3 had poorer survival than those with PS 0 or 1. The median survival times for patients with PS 0 or 1 and PS 2 or 3 were 22.1 and 4.3 months, respectively. Among 131 patients, no fatal adverse events occurred, although chemotherapy was discontinued due to adverse events in 28 patients. Conclusions: Chemotherapy for advanced STS in elderly patients may be effective in those with good PS, although it should be considered to evaluate the benefits and risks of cytotoxic chemotherapy.

5 January 2021 in Journal of Orthopaedic Science
Verified
Journal Article
Closed access
KKKatsuhisa Kawanami
Katsuhisa Kawanami
YKYukihiro Kajita
Yukihiro Kajita
YHYohei Harada
Yohei Harada
ETEmiko Takahashi
Emiko Takahashi
MDMasataka Deie
Masataka Deie